FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

413948005: Daunorubicin liposome (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3495338018 Daunorubicin liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3495339014 Daunorubicin liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daunorubicin liposome (substance) Is a Liposomal agent (substance) true Inferred relationship Some
Daunorubicin liposome (substance) Is a Daunorubicin (substance) false Inferred relationship Some
Daunorubicin liposome (substance) Is a Anthracycline (substance) true Inferred relationship Some
Daunorubicin liposome (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Daunorubicin (substance) true Inferred relationship Some
Daunorubicin liposome (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Liposomal daunorubicin 2mg/mL injection emulsion 25mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daunorubicin liposome (substance) Inferred relationship Some
Daunorubicin citrate liposomal 2mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daunorubicin liposome (substance) Inferred relationship Some
Product containing daunorubicin liposome The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daunorubicin liposome (substance) Inferred relationship Some
Daunorubicin citrate liposome (substance) Is a False Daunorubicin liposome (substance) Inferred relationship Some
Daunorubicin citrate liposome (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Daunorubicin liposome (substance) Inferred relationship Some
Product containing only daunorubicin liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daunorubicin liposome (substance) Inferred relationship Some 1
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daunorubicin liposome (substance) Inferred relationship Some 1
Daunorubicin hydrochloride liposome (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Daunorubicin liposome (substance) Inferred relationship Some
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Daunorubicin liposome (substance) Inferred relationship Some 2
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Daunorubicin liposome (substance) Inferred relationship Some 2
Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daunorubicin liposome (substance) Inferred relationship Some 2
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daunorubicin liposome (substance) Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start